Table 1.

Lists of Cases in the Pathologic Complete Responder (pCR) and Partial Responder (pPR) Subgroups in Our Study

	#days (FU-BL)	#LM (tumor)	#LM (normal)	#LM (all)
pPR group
Patient 1	14	63	59	122
Patient 2	29	25	55	80
Patient 3	13	64	60	124
Patient 4	14	22	45	67
Patient 5	14	90	16	106
Patient 6	56	53	55	108
Mean ± stdev	23 ± 17	53 ± 26	48 ± 17	101 ± 23
pCR group
Patient 7	61	42	30	72
Patient 8	14	14	48	62
Patient 9	60	16	45	61
Patient 10	56	8	19	27
Patient 11	14	22	81	103
Patient 12	55	41	20	61
Patient 13	21	51	25	76
Patient 14	14	31	87	118
Mean ± stdev	37 ± 23	28 ± 15	44 ± 27	73 ± 28
All patients
Mean ± stdev	31 ± 21	39 ± 23	46 ± 22	85 ± 29

The time interval between the follow-up and baseline images, and the number of manually annotated landmarks in tumor and normal tissue regions are listed for each patient. (FU: follow-up; BL: baseline; LM: landmarks.)